Lakeland Community Hospital Watervliet
Lakeland Community Hospital Watervliet was paid $9.05M by Medicaid between Jan 2018 and Dec 2024, across 86 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 97% of everything it billed.
NILES, MI 49120
Next to other Rural Health Clinic/Center providers in Michigan
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 63,433 | $1.33M | |
| 2019 | 61,769 | $1.31M | |
| 2020 | 50,628 | $1.03M | |
| 2021 | 57,935 | $1.21M | |
| 2022 | 61,123 | $1.30M | |
| 2023 | 67,181 | $1.52M | |
| 2024incomplete | 58,385 | $1.35M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 97% | 149,378 | 129,020 | $8.79M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 67,846 | 62,340 | $64K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 33,641 | 32,092 | $34K |
| 90651 | <1% | 2,516 | 2,514 | $32K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 12,542 | 10,906 | $30K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 9,018 | 8,995 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,312 | 1,295 | $8K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 12,952 | 12,916 | $7K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 6,642 | 6,638 | $6K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 352 | 352 | $6K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 1,052 | 1,041 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13,103 | 13,042 | $5K |
74 more codes
| 90686 | <1% | 5,135 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,139 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,613 | $4K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,287 | $4K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,792 | $3K |
| 90715 | <1% | 2,153 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 4,125 | $3K |
| 99381 | <1% | 366 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,143 | $2K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,033 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,709 | $2K |
| 90474 | <1% | 3,430 | $1K | |
| 90671 | <1% | 1,421 | $1K | |
| 90716 | <1% | 3,524 | $681.30 | |
| 99385 | <1% | 53 | $596.22 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,325 | $590.70 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,670 | $533.91 |
| 99383 | <1% | 79 | $505.00 | |
| 90750 | <1% | 26 | $445.20 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 592 | $425.60 |
| 90620 | <1% | 416 | $349.80 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 752 | $280.18 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 290 | $269.27 |
| 90656 | <1% | 351 | $261.50 | |
| 81025 | <1% | 1,551 | $218.64 | |
| 99384 | <1% | 13 | $198.74 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 4,283 | $196.00 |
| 96127 | <1% | 3,599 | $184.78 | |
| G0008 | Administration of influenza virus vaccine | <1% | 3,873 | $181.28 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 459 | $158.64 |
| 90707 | <1% | 3,519 | $154.30 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 822 | $147.28 |
| 17110 | <1% | 82 | $133.52 | |
| 96380 | <1% | 62 | $131.16 | |
| 99386 | <1% | 12 | $117.10 | |
| 85018 | <1% | 2,539 | $112.00 | |
| 72110 | <1% | 12 | $110.52 | |
| 81003 | <1% | 3,791 | $110.15 | |
| 90714 | <1% | 13 | $89.33 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 700 | $88.44 |
| 74018 | <1% | 18 | $73.70 | |
| 90473 | <1% | 1,092 | $54.00 | |
| 99406 | <1% | 654 | $44.91 | |
| 81002 | <1% | 1,176 | $38.65 | |
| 90688 | <1% | 283 | $17.84 | |
| 92551 | <1% | 18 | $13.76 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 77 | $12.50 |
| 90700 | 0% | 1,633 | $0.00 | |
| 90633 | 0% | 3,859 | $0.00 | |
| 90670 | 0% | 5,879 | $0.00 | |
| 69210 | 0% | 13 | $0.00 | |
| 90734 | 0% | 2,172 | $0.00 | |
| 90461 | 0% | 845 | $0.00 | |
| 90685 | 0% | 334 | $0.00 | |
| 69209 | 0% | 25 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 130 | $0.00 |
| 90380 | 0% | 12 | $0.00 | |
| 87210 | 0% | 212 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 14 | $0.00 |
| 31575 | 0% | 85 | $0.00 | |
| 99173 | 0% | 37 | $0.00 | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 0% | 12 | $0.00 |
| 73630 | 0% | 12 | $0.00 | |
| 90723 | 0% | 5,766 | $0.00 | |
| 90381 | 0% | 49 | $0.00 | |
| 90680 | 0% | 5,171 | $0.00 | |
| 90696 | 0% | 1,562 | $0.00 | |
| 31231 | 0% | 40 | $0.00 | |
| 90647 | 0% | 5,457 | $0.00 | |
| 36416 | 0% | 352 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 76 | $0.00 |
| 94760 | 0% | 245 | $0.00 | |
| 90674 | 0% | 20 | $0.00 | |
| 99024 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.